$TransMedics(TMDX.US) | Stifel maintains 𝐇𝐨𝐥𝐝 on 𝐓𝐫𝐚𝐧𝐬𝐌𝐞𝐝𝐢𝐜𝐬, 𝐜𝐮𝐭𝐬 𝐏𝐓 𝐭𝐨 $𝟕𝟓 𝐟𝐫𝐨𝐦 $𝟖𝟓
Analyst flags rising competition concerns from XVIVO's HOPE device, cutting revenue estimates based on KOL feedback indicating a substantial market share shift.
What's on your mind?
$TransMedics(TMDX.US) | Stifel maintains 𝐇𝐨𝐥𝐝 on 𝐓𝐫𝐚𝐧𝐬𝐌𝐞𝐝𝐢𝐜𝐬, 𝐜𝐮𝐭𝐬 𝐏𝐓 𝐭𝐨 $𝟕𝟓 𝐟𝐫𝐨𝐦 $𝟖𝟓
Analyst flags rising competition concerns from XVIVO's HOPE device, cutting revenue estimates based on KOL feedback indicating a substantial market share shift.